Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regulatory B cells, helminths, and multiple sclerosis.
You're the Flight Surgeon.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Tried-and-True Antibiotic May Block Conversion to MS
Seronegative neuromyelitis optica presenting with life-threatening respiratory failure.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
Applications of coherent Raman scattering microscopies to clinical and biological studies.
Models for treating depression in specialty medical settings: a narrative review.
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
The relationship between muscle pain and fatigue.
"Media, politics and science policy: MS and evidence from the CCSVI Trenches".
Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.
Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis.
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood-Brain Barrier.
Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study.
Gait variability and multiple sclerosis.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].
Pages
« first
‹ previous
…
416
417
418
419
420
421
422
423
424
…
next ›
last »